Clinical Trial

Clinical Efficacy of Transarterial Chemoembolization in Elderly Patients With Advanced Unresectable Colorectal Cancer

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
We plan to conduct a prospective, two-arm, open-label phase Ⅱ study to evaluate whether transarterial chemoembolization with FOLFOX plus/minus intravenous cetuximab/bevacizumab significantly improves the efficacy and safety compared with systemic FOLFOX therapy plus/minus cetuximab/bevacizumab in elderly patients with advanced unresectable colorectal cancer.
Trial Details
NCT Number NCT07209384
Lead Sponsor Junpeng Wang
Collaborators: Peking Union Medical College Hospital
Conditions Unresectable Colorectal Cancer, Advanced Malignancy, Elderly (People Aged 65 or More)
Enrollment 50 participants
Start Date 2025-10-01
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-07